Drug intelligence / Profile preview

caffeic acid + dexamethasone + prednisone

Development stage
Preclinical
Lead developer
Merck
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral (most Common For All Three Agents Individually)
01

Overview

This is a combination of three active ingredients: - **Caffeic acid** is a naturally occurring polyphenolic compound found in many plants and foods. It has antioxidant, anti-inflammatory, and potential immunomodulatory properties. - **Dexamethasone** is a potent synthetic glucocorticoid corticosteroid with strong anti-inflammatory and immunosuppressive effects. It acts by binding to the glucocorticoid receptor, modulating gene expression to suppress inflammation and immune responses. - **Prednisone** is another synthetic glucocorticoid corticosteroid with similar but less potent anti-inflammatory and immunosuppressive actions compared to dexamethasone. There are no known marketed pharmaceutical products that combine all three agents into a single formulation. However, studies have examined the co-administration of caffeine (a related methylxanthine) or caffeic acid derivatives with glucocorticoids like dexamethasone or prednisone for synergistic effects on surfactant protein expression in pulmonary cells[1]. Dexamethasone and prednisone are sometimes used sequentially or in combination for certain inflammatory conditions such as asthma exacerbations[6][10]. The mechanisms involve inhibition of pro-inflammatory cytokines, suppression of leukocyte infiltration, reduction of capillary permeability (for both steroids), while caffeic acid may exert additional antioxidant effects.

02

Targets

RELA (Nuclear Factor Kappa B Subunit p65)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GR (Glucocorticoid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on caffeic acid + dexamethasone + prednisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on caffeic acid + dexamethasone + prednisone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call